EP14.05-004 Temozolomide and Atezolizumab as Second Line Treatment for Extensive Stage Small Cell Lung Cancer: A Randomized, Multi-Cohort Phase 2 Trial

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2022-09, Vol.17 (9), p.S544-S545
Main Authors: Owen, D.H., Durm, G.A., Wei, L., Pilcher, C., Ferguson, S., Benner, B., Jukich, M., Sukrithan, V., Konda, B., Savardekar, H., Spakowicz, D., Schwarz, E., Norman, R.O., Wesolowski, R., Carson, W.E., Kaufman, J., Alahmadi, A., Memmott, R., Shields, P., He, K., Bertino, E.M., Presley, C.J., Carbone, D.P., Otterson, G.A.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
DOI:10.1016/j.jtho.2022.07.979